Scientific CornerTop Articles
Editorial commentary: First European Multiple Sclerosis Guidelines – why are they needed and what are they good for?
In 2016, the EAN president Günther Deuschl and ECTRIMS (European Committee for Treatment and Research in MS) president Xavier Montalban have decided to join the forces of the two societies, and prepare a common guideline for the treatment of multiple sclerosis (MS). In view of the recent increase of medications approved for relapsing- and progressive MS, evidence-based guidance is needed to ensure standardized treatment of MS patients throughout Europe.










Learn from Horizon 2020 to address unmet medical need in Europe
Viewpoint: BioMed Alliance Board member Prof. Ulrich Jaeger argues that EU funding is crucial in allowing medical researchers across member states to collaborate in the development of new treatments.…
Highlights from the European Parliament meeting ‘Ensuring equitable access to high-quality treatment in brain, mind and pain disorders – Case-Studies from across Europe’ on 22 November, 2017.
A meeting of the Members of the European Parliament…
by Anna Sauerbier
World’s Brain Initiatives Move Forward Together
http://www.humanbrainproject.eu/en/follow-hbp/news/worlds-brain-initiatives-move-forward-together/
New trial shows Huntington’s drug could slow progress of disease
http://eurohuntington.org/2017/12/11/2328/
New scientific yardstick to help early diagnosis of Alzheimer’s disease
https://ec.europa.eu/jrc/en/news/new-scientific-yardstick-help-early-diagnosis-alzheimers-disease
Neurologists urge doctors to…